Cancer Research Communications
American Association for Cancer Research
About the journal
Cancer Research Communications is an open-access journal published by American Association for Cancer Research in United States, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 2,550 USD. Declared review time at DOAJ: 9 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- American Association for Cancer Research
- ISSN
- 2767-9764
- Country
- United States
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,550 USD
- Articles in DOAJ
- 0
- Declared review time
- 9 weeks
- Declared peer-review model
- peer_review
- Official website
- https://aacrjournals.org/cancerrescommun
Index listings
- DOAJ · 2022-12-06
- MEDLINE · 2021-01-01
- PUBMED · 2022-03-10
- Indexing
- DOAJ · MEDLINE · PUBMED
- APC
- 2,550 USD
- Declared review time (DOAJ)
- 9 weeks
- Actual review time (measured)
- 142 days received→accepted — computed from PubMed (n=100)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
0
Average review time (journal-declared via DOAJ)
9weeks
Works in OpenAlex
956
Last recorded publication year
2026
h-index
31
i10-index
283
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2022-12-06
- Added to DOAJ
- 2022-12-06
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSS
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 97%
- ORCID iDs in current deposits
- 98%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- Cancer res communCRC
- Source type
- journal
- NLM unique ID (PubMed)
- 9918281580506676
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Immune cells in cancer
- Immune cells in cancer
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
Show all subjects (50)
- CAR-T cell therapy research
- CAR-T cell therapy research
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- PARP inhibition in cancer therapy
- PARP inhibition in cancer therapy
- Lung Cancer Treatments and Mutations
- Prostate Cancer Treatment and Research
- Single-cell and spatial transcriptomics
- Single-cell and spatial transcriptomics
- Prostate Cancer Treatment and Research
- Epigenetics and DNA Methylation
- Cancer-related Molecular Pathways
- Lung Cancer Treatments and Mutations
- Cancer-related Molecular Pathways
- Epigenetics and DNA Methylation
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
- Protein Degradation and Inhibitors
- Protein Degradation and Inhibitors
- Sarcoma Diagnosis and Treatment
- Microtubule and mitosis dynamics
- Glioma Diagnosis and Treatment
- Sarcoma Diagnosis and Treatment
- Glioma Diagnosis and Treatment
- Pancreatic and Hepatic Oncology Research
- Microtubule and mitosis dynamics
- DNA Repair Mechanisms
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- PI3K/AKT/mTOR signaling in cancer
- Acute Myeloid Leukemia Research
- Pancreatic and Hepatic Oncology Research
- Acute Myeloid Leukemia Research
- PI3K/AKT/mTOR signaling in cancer
- Ubiquitin and proteasome pathways
Keywords (DOAJ)
- cancer
- oncology
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ